Stoxline.com

Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations

Galectin Therapeutics Inc. (GALT)

4.01   -0.24 (-5.65%) 05-23 16:00
Open: 4.25 Pre. Close: 4.25
High: 4.35 Low: 3.99
Volume: 1,097,298 Market Cap: 183M

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 4.565 - 4.602 4.602 - 4.627
Low: 3.921 - 3.958 3.958 - 3.982
Close: 3.962 - 4.019 4.019 - 4.057

Technical analysis

as of: 2019-05-23 4:25:25 PM
Overall:       
Stoxline posted a SELL today, same as yesterday. Downward movement continues.
Target: Six months: 5.37     One year: 5.82
Support: Support1: 3.99    Support2: 3.32
Resistance: Resistance1: 4.60    Resistance2: 4.98
Pivot: 4.55
Moving Average: MA(5): 4.40     MA(20): 4.53
MA(100): 4.71     MA(250): 5.10
MACD: MACD(12,26): -0.08     Signal(9): -0.03
Stochastic oscillator: %K(14,3): 18.89     %D(3): 37.14
RSI: RSI(14): 36.10
52-week: High: 9.49  Low: 3.17  Change(%): -1.7
Average Vol(K): 3-Month: 39953  10-Days: 37318

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BEARISH in short-term; and BEARISH in mid-long term.
GALT has closed below the lower band by 19.7%. If price is in a downtrend band; this downward trend in price might continue. However a short term pullback inside the band is likely. Bollinger Bands are 32% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

Wed, 13 Feb 2019 22:37:03 Z
Conatus (CNAT) Completes Enrollment in Phase II NASH Study

Wed, 13 Feb 2019 16:44:52 Z
Ascendis Pharma Files IND for Hypoparathyroidism Candidate

Mon, 04 Feb 2019 16:13:09 Z
Alkermes Sinks as FDA Refuses to Approve Depression Drug

Fri, 01 Feb 2019 16:51:26 Z
AVEO Oncology Plunges on Delay in Filing Fotivda NDA With FDA

Wed, 30 Jan 2019 17:02:40 Z
Is Galectin Therapeutics (GALT) Stock Outpacing Its Medical Peers This Year?

Financial Analysis

Growth
Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency NA
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Click here to get more fundamental analysis.
Tweet this page Share on Facebook
Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare
Industry:  Drug Manufacturers - Specialty Generic
Shares Out. (M) 45.59
Shares Float (M) 37.85
% Held by Insiders
% Held by Institutions 17.00
Shares Short (K)
Shares Short P. Month (K)

Stock Financials

EPS -0.380
EPS Est. Current Year -0.530
EPS Est. Next Year -0.520
EPS Est. Next Quarter -0.130
Forward EPS -0.690
Book Value (p.s.) 46.370
PEG Ratio
Profit Margin
Operating Margin
Return on Assets (ttm) -318.1
Return on Equity (ttm) 3352.0
Qtrly Rev. Growth
Gross Profit (p.s.)
Sales Per Share
EBITDA (p.s.)
Qtrly Earnings Growth
Operating Cash Flow (M) -9.95
Levered Free Cash Flow (M) -4.28

Stock Valuations

P/E -10.55
P/E Growth Ratio -0.06
P/BV 0.09
P/S
P/CF -18.38

Dividends & Splits

Dividend
Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
Forward Dividend
Last Split Date 2012-03-23
Last Split Ratio -1e+010
7 Binary Options
Your Ad Here
android_stock_chart
Stock Chart
stoxline_lite
Stoxline Lite
stoxline_pro
Stoxline Pro
Option_Calculator
Option Calculator
(c) 2006-2019 Stoxline.com | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.